Type 2 diabetes is a very common health condition. It happens when the body cannot use insulin properly, which leads to high levels of sugar in the blood.
Over time, high blood sugar can damage the heart, kidneys, eyes, and other parts of the body. Because of this, keeping blood sugar under control is very important.
Many people with Type 2 diabetes start their treatment with a medicine called metformin. This drug has been used for many years and works well for many patients. It helps the body use insulin better and lowers the amount of sugar made by the liver.
However, diabetes is a long-term condition, and for some people, metformin alone is not enough after a while. Their blood sugar levels may rise again, and they need extra treatment.
Researchers from Thomas Jefferson University have now found a new way to help these patients. Their study shows that combining two other diabetes drugs, called dapagliflozin and exenatide, can provide stronger and longer-lasting control of blood sugar.
The study included 695 adults with Type 2 diabetes. All of them were already taking metformin, but their blood sugar levels were still too high. The researchers divided them into three groups to test different treatments.
One group added exenatide, which is given as a weekly injection. Another group took dapagliflozin, which is a pill taken once a day. The third group used both exenatide and dapagliflozin together, along with metformin.
The researchers followed these participants for two years. At the end of the study, the results were clear. People who took both medications together had better control of their blood sugar than those who took only one of the drugs. More importantly, the benefits lasted over time, which is very important for managing a lifelong condition like diabetes.
These two medicines work in different ways, which is why they are effective when used together. Dapagliflozin helps the body remove extra sugar through urine. It works through the kidneys and does not depend on insulin.
Exenatide works differently. It helps the body release more insulin after meals, slows down digestion, reduces sugar production in the liver, and helps people feel full for longer. Because of this, people may eat less and lose weight.
When these two drugs are combined, they support each other. In the study, patients not only had lower blood sugar, but they also lost weight and saw improvements in their blood pressure. These are important benefits, because many people with Type 2 diabetes also struggle with weight and heart health.
The study also found that the treatment was safe. Over the two years, there were no unexpected side effects or major safety concerns. This is important, because safety is a key factor when adding new medications.
The results were published in the journal Diabetes Care. The lead researcher, Dr. Serge Jabbour, believes that this combination treatment could be very helpful for patients who are not getting enough benefit from metformin alone.
This research offers new hope for people living with Type 2 diabetes. It shows that there are more options available to manage the condition effectively. Instead of relying on a single drug, combining treatments that work in different ways may provide better and more lasting results.
As doctors learn more from studies like this, they may be able to create more personalized treatment plans. This could help patients control their blood sugar, improve their overall health, and live better lives over the long term.
If you care about diabetes, please read studies about Vitamin D and type 2 diabetes, and to people with diabetes, some fruits are better than others.
For more health information, please see recent studies that low calorie diets may help reverse diabetes, and 5 vitamins that may prevent complication in diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
